Current Liabilities
Accounts Payable
Gilead Sciences Accounts Payable decreased by 9.8% to $645M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.5%, from $737M to $645M. Over 5 years (FY 2020 to FY 2025), Accounts Payable shows a downward trend with a -3.3% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 7, 2026
How to read this metric
An increase may indicate improved cash flow management by delaying payments, while a decrease suggests faster settlement of obligations.
Detailed definition
Accounts payable represents the short-term financial obligations owed to suppliers and vendors for goods and services re...
Peer comparison
Common across all sectors; analyzed alongside days payable outstanding (DPO) to assess payment efficiency.
Metric ID:
accounts_payableHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $608M | $585M | $705M | $583M | $565M | $614M | $905M | $627M | $622M | $586M | $550M | $622M | $537M | $903M | $833M | $737M | $582M | $808M | $715M | $645M |
| QoQ Change | — | -3.8% | +20.5% | -17.3% | -3.1% | +8.7% | +47.4% | -30.7% | -0.8% | -5.8% | -6.1% | +13.1% | -13.7% | +68.2% | -7.8% | -11.5% | -21.0% | +38.8% | -11.5% | -9.8% |
| YoY Change | — | — | — | — | -7.1% | +5.0% | +28.4% | +7.5% | +10.1% | -4.6% | -39.2% | -0.8% | -13.7% | +54.1% | +51.5% | +18.5% | +8.4% | -10.5% | -14.2% | -12.5% |
Range$537M – $905M
CAGR+1.3%
Avg YoY Growth+5.1%
Median YoY Growth+2.1%
Current Streak2 quarters decline
Accounts Payable at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's accounts payable?
- Gilead Sciences (GILD) reported accounts payable of $645M in Q1 2026.
- How has Gilead Sciences's accounts payable changed year-over-year?
- Gilead Sciences's accounts payable decreased by 12.5% year-over-year, from $737M to $645M.
- What is the long-term trend for Gilead Sciences's accounts payable?
- Over 5 years (2020 to 2025), Gilead Sciences's accounts payable has grown at a -3.3% compound annual growth rate (CAGR), from $844M to $715M.
- What does accounts payable mean?
- Money the company owes to its suppliers for goods and services.